175 related articles for article (PubMed ID: 24935581)
1. Tissue microarray immunohistochemical profiles of p53 and pRB in hepatocellular carcinoma and hepatoblastoma.
Azlin AH; Looi LM; Cheah PL
Asian Pac J Cancer Prev; 2014; 15(9):3959-63. PubMed ID: 24935581
[TBL] [Abstract][Full Text] [Related]
2. RB tumor suppressor gene expression in hepatocellular carcinomas from patients infected with the hepatitis B virus.
Hsia CC; Di Bisceglie AM; Kleiner DE; Farshid M; Tabor E
J Med Virol; 1994 Sep; 44(1):67-73. PubMed ID: 7798888
[TBL] [Abstract][Full Text] [Related]
3. Primary malignant epithelial tumors of the liver in children: a study of DNA content and oncogene expression.
Zerbini MC; Sredni ST; Grier H; Cristofani LM; Latorre MR; Hollister KA; Alves VA; Weinberg DS; Perez-Atayde AR
Pediatr Dev Pathol; 1998; 1(4):270-80. PubMed ID: 10463288
[TBL] [Abstract][Full Text] [Related]
4. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
[TBL] [Abstract][Full Text] [Related]
5. Hepatic progenitor cells in liver cancers from Asian children.
Ward SC; Thung SN; Lim KH; Tran TT; Hong TK; Hoang PL; Jang JJ; Park YN; Abe K
Liver Int; 2010 Jan; 30(1):102-11. PubMed ID: 19793197
[TBL] [Abstract][Full Text] [Related]
6. The genomic landscape of hepatoblastoma and their progenies with HCC-like features.
Eichenmüller M; Trippel F; Kreuder M; Beck A; Schwarzmayr T; Häberle B; Cairo S; Leuschner I; von Schweinitz D; Strom TM; Kappler R
J Hepatol; 2014 Dec; 61(6):1312-20. PubMed ID: 25135868
[TBL] [Abstract][Full Text] [Related]
7. P53 but not p16INK4a induces growth arrest in retinoblastoma-deficient hepatocellular carcinoma cells.
Morel AP; Unsal K; Cagatay T; Ponchel F; Carr B; Ozturk M
J Hepatol; 2000 Aug; 33(2):254-65. PubMed ID: 10952243
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
9. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
[TBL] [Abstract][Full Text] [Related]
10. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
Choi YL; Park SH; Jang JJ; Park CK
J Korean Med Sci; 2001 Aug; 16(4):424-32. PubMed ID: 11511787
[TBL] [Abstract][Full Text] [Related]
11. Expression ratio of hepatocyte nuclear factor-1 to variant hepatocyte nuclear factor-1 in differentiation of hepatocellular carcinoma and hepatoblastoma.
Ninomiya T; Hayashi Y; Saijoh K; Ohta K; Yoon S; Nakabayashi H; Tamaoki T; Kasuga M; Itoh H
J Hepatol; 1996 Oct; 25(4):445-53. PubMed ID: 8912143
[TBL] [Abstract][Full Text] [Related]
12. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
[TBL] [Abstract][Full Text] [Related]
13. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
[TBL] [Abstract][Full Text] [Related]
14. Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution.
Zhou S; Parham DM; Yung E; Pattengale P; Wang L
Histopathology; 2015 Dec; 67(6):905-13. PubMed ID: 25939253
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of SIRT1 in hepatocellular carcinoma.
Song S; Luo M; Song Y; Liu T; Zhang H; Xie Z
J Coll Physicians Surg Pak; 2014 Nov; 24(11):849-54. PubMed ID: 25404446
[TBL] [Abstract][Full Text] [Related]
16. Genomic Profiling Reveals Unique Molecular Alterations in Hepatoblastomas and Adjacent Hepatocellular Carcinomas in B6C3F1 Mice.
Bhusari S; Pandiri AR; Nagai H; Wang Y; Foley J; Hong HH; Ton TV; DeVito M; Shockley KR; Peddada SD; Gerrish KE; Malarkey DE; Hooth MJ; Sills RC; Hoenerhoff MJ
Toxicol Pathol; 2015 Dec; 43(8):1114-26. PubMed ID: 26289556
[TBL] [Abstract][Full Text] [Related]
17. Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection.
Long J; Wang Y; Li M; Tong WM; Jia JD; Huang J
Oncol Rep; 2013 Jul; 30(1):119-24. PubMed ID: 23624687
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma.
Zhang ZY; Hong D; Nam SH; Kim JM; Paik YH; Joh JW; Kwon CH; Park JB; Choi GS; Jang KY; Park CK; Kim SJ
J Hepatol; 2015 Jan; 62(1):121-30. PubMed ID: 25131770
[TBL] [Abstract][Full Text] [Related]
19. Brain metastasis from hepatocellular carcinoma associated with hepatitis B virus.
Frati A; Salvati M; Giarnieri E; Santoro A; Rocchi G; Frati L
J Exp Clin Cancer Res; 2002 Sep; 21(3):321-7. PubMed ID: 12385572
[TBL] [Abstract][Full Text] [Related]
20. Association of RNF43 with cell cycle proteins involved in p53 pathway.
Xie H; Xing C; Cao G; Wei B; Xu X; Song P; Chen L; Chen H; Yin S; Zhou L; Zheng S
Int J Clin Exp Pathol; 2015; 8(11):14995-5000. PubMed ID: 26823834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
